Crewe Advisors’s Vericel Corp VCEL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$5.41K Sell
168
-138
-45% -$4.9K ﹤0.01% 765
2025
Q4
$11K Buy
306
+32
+12% +$1.18K ﹤0.01% 604
2025
Q3
$8.62K Buy
+274
New +$9.84K ﹤0.01% 656
2024
Q3
Sell
-256
Closed -$11.7K 987
2024
Q2
$11.7K Buy
256
+192
+300% +$9.05K ﹤0.01% 657
2024
Q1
$3.33K Buy
+64
New +$2.81K ﹤0.01% 802

Other funds holding VCEL

Crewe Advisors's VCEL Position: Q1 2026 in Review

Crewe Advisors reduced its Vericel Corp (VCEL) stake by 45% in Q1 2026, selling an estimated $4.9K and leaving 168 shares worth $5.41K. The position accounts for ﹤0.01% of the portfolio, ranked #765.

Crewe Advisors first reported a position in VCEL in Q1 2024 and has held it in 5 quarters since. The position peaked at $11.7K in Q2 2024. 279 funds tracked by Wall St. Rank hold VCEL as of Q1 2026.

  • Crewe Advisors held 168 shares of Vericel Corp worth $5.41K as of Q1 2026.
  • Crewe Advisors sold 138 Vericel Corp shares in Q1 2026, an estimated $4.9K.
  • Vericel Corp made up ﹤0.01% of Crewe Advisors's portfolio in Q1 2026, its #765 holding.
  • Crewe Advisors first reported a position in Vericel Corp in Q1 2024 and has held it in 5 quarters since.
  • Crewe Advisors's Vericel Corp position peaked at $11.7K in Q2 2024.
  • 279 funds tracked by Wall St. Rank held Vericel Corp as of Q1 2026.

Based on Crewe Advisors's 13F filing for Q1 2026, filed 7 May 2026.